3 Reasons to Avoid GILD and 1 Stock to Buy Instead [Yahoo! Finance]
Gilead Sciences, Inc. (GILD)
Last gilead sciences, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.gilead.com
Company Research
Source: Yahoo! Finance
Its momentum hasn't stopped as it's also gained 27.8% in the last six months, beating the S&P by 26.8%. Is there a buying opportunity in Gilead Sciences, or does it present a risk to your portfolio? Dive into our full research report to see our analyst team's opinion, it's free Why Is Gilead Sciences Not Exciting? We're happy investors have made money, but we don't have much confidence in Gilead Sciences. Here are three reasons there are better opportunities than GILD and a stock we'd rather own. 1. Long-Term Revenue Growth Disappoints Examining a company's long-term performance can provide clues about its quality. Even a bad business can shine for one or two quarters, but a top-tier one grows for years. Over the last five years, Gilead Sciences grew its sales at a tepid 3.6% compounded annual growth rate. This was below our standard for the healthcare sector. Gilead Sciences Quarterly Revenue 2. Free Cash Flow Margin Dropping If you've followed StockStory for a while,
Show less
Read more
Impact Snapshot
Event Time:
GILD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GILD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GILD alerts
High impacting Gilead Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
GILD
News
- Manta Cares and Gilead Sciences Collaborate to Support Patients Navigating Metastatic Lung and Breast CancerPR Web
- 3 Cash-Flow Machines Investors May Want Heading Into 2026 [Yahoo! Finance]Yahoo! Finance
- Gilead Sciences at Barclays: CFO touts YEZTUGO launch, Arcellx deal and “long cycle” growth [Yahoo! Finance]Yahoo! Finance
- Gilead Sciences, Inc. (GILD): Growth Prospects Backed by Analyst Upgrades [Yahoo! Finance]Yahoo! Finance
- Will GILD's Move to Acquire ACLX Boost Its Cell Therapy Franchise? [Yahoo! Finance]Yahoo! Finance
GILD
Earnings
- 2/10/26 - Beat
GILD
Sec Filings
- 3/17/26 - Form 4
- 3/17/26 - Form 4
- 3/16/26 - Form 144
- GILD's page on the SEC website